Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Juniper (JNPR -1.5%) is reviewing options for its enterprise networking ops following failed attempts to sell some of its assets, Reuters reports. Among the assets reportedly put on the block was Juniper's NetScreen security hardware unit, which has been bleeding share to upstarts. Juniper is now said to be eying acquisitions (potentially financed via private stock sales), albeit "with a longer-term view of a sale or spin-off." Juniper's enterprise sales fell 10% Y/Y in Q4, while its service provider sales rose 9%.
Get Latest News, Updates on JNPR Here
U.S. Silica (SLCA +18.7%) soars after its Q4 earnings beat was driven by higher than expected revenues and operating income from its oil and gas segment. Overall sales volumes increased to 1.8M tons, up 10% Y/Y. Contribution margin of $50.5M was up 32% Y/Y. Expects Q1 revenues of $115M-123M vs. $114.2M consensus.
Is SLCA a Strong Buying Opportunity After The Recent Slump? Find out Here
Diabetes drugs sold by Merck & Co. (MRK -0.7%) and Bristol-Myers Squibb Co. (BMY +0.1%) may double a user’s risk of developing an inflammation of the pancreas linked to cancer and kidney failure, according to a recent study in the journal JAMA Internal Medicine. Analysis of insurance records indicate that patients hospitalized with pancreatitis were twice as likely to be taking Januvia, MRK’s top-selling drug, or BMY’s Byetta, than a control group of diabetics who didn’t have pancreatitis. Both drugs increase GLP-1, a hormone that stimulates insulin production from the pancreas.
Is MRK Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Dollar Tree (DLTR +0.9%) in focus: Goldman Sachs backs its Outperform rating on the retailer and says any weakness following tomorrow's earnings will provide investors a nice entry point. The firm notes that Dollar Tree has outpaced sales and profit at Wal-Mart since the economic downturn and thinks the trend will continue. SA author Bret Jensen isn't as bullish on the dollar store group though with some of the supports from lower-end consumer spending being removed.
Get latest News, Updates on DLTR Here
About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)